| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
JSH 23
|
749886-87-1 |
4-甲基-N1-(3-苯基丙基)-1,2-苯二胺
|
JSH-23;JSH23;JSH 23;JSH-23;JSH23;JSH 23;NF-ΚB ACTIVATION INHIBITOR II;4-甲基-N1-(3-苯丙基)-1,2-苯二胺;4-甲基-N1-(3-苯丙基)-1;4-甲基-N1-(3-苯基丙基)-1,2-苯二胺
|
C16H20N2 |
240.3434 | |
|
JNK-IN-8
|
1410880-22-6 |
JNK-IN-8
|
3-[[4-(二甲基氨基(-1-氧代-2-丁烯-1-基]氨基]-N-[3-甲基-4-[[4-(3-吡啶基(-2-嘧啶基]氨基]苯基]苯甲酰胺;CS-1339
|
C29H29N7O2 |
507.58626 | |
|
JNJ7777120
|
459168-41-3 |
JNJ777712
|
(5-氯-1H-吲哚-2-基((4-甲基哌嗪-1-基(甲酮;1-[(5-氯-1H-吲哚-2-基(羰基]-4-甲基哌嗪;CS-593;JNJ-7777120;JNJ7777120
|
C14H16ClN3O |
277.753 | |
|
JNJ 26854165
|
881202-45-5 |
N-[2-(1H-吲哚-3-基)乙基]-N'-(4-吡啶基)-1,4-苯二胺
|
CS-389;N-[2-(1H-吲哚-3-基)乙基]-N'-(4-吡啶基)-1,4-苯二胺>98%;JNJ 26854165;JNJ26854165;JNJ-26854165;N-[2-(1H-吲哚-3-基)乙基]-N'-(4-吡啶基)-1,4-苯二胺;N-[2-(1H-吲哚-3-基)乙基]-N'-(4-吡啶基)-1,4-苯二胺(JNJ26854165);HDM2泛素连接酶拮抗剂
|
C21H20N4 |
328.42 | 200-256-5 |
|
J 147
|
1146963-51-0 |
N-(2,4-DIMETHYLPHENYL)-N'-(3-METHOXYBENZYLIDENE)ACETOHYDRAZIDE
|
J-147>98%;CS-1446;N-(2,4-DIMETHYLPHENYL)-N'-(3-METHOXYBENZYLIDENE)ACETOHYDRAZIDE;2,2,2-三氟乙酸 1-(2,4-二甲基苯基)-2-[(3-甲氧基苯基)亚甲基]酰肼
|
C18H17F3N2O2 |
350.33499 | |
|
Metformin hydrochloride
|
1115-70-4 |
盐酸二甲双胍
|
二甲基双胍;二甲双胍盐酸盐;甲福明二甲双胍盐酸盐;1,2-二甲基双胍盐酸盐;盐酸二甲双胍对照品;盐酸二甲双胍(USP美国药典标准品);甲福明二甲双胍盐酸;甲福明二甲双胍
|
C4H11N5.HCL |
165.62 | 214-230-6 |
|
ITD-1
|
1099644-42-4 |
ITD 1
|
ETHYL 4-{[1,1'-BIPHENYL]-4-YL}-2,7,7-TRIMETHYL-5-OXO-1,4,6,8-TETRAHYDROQUINOLINE-3-CARBOXYLATE;ITD-1;4-[1,1'-Biphenyl]-4-yl-1,4,5,6,7,8-hexahydro-2,7,7-trimethyl-5-oxo-3-quinolinecarboxylic acid ethyl ester;AOB6123;SCHEMBL3239096
|
|||
|
ISRIB
|
548470-11-7 |
N,N'-((1R,4R)-CYCLOHEXANE-1,4-DIYL)BIS(2-(4-CHLOROPHENOXY)ACETAMIDE)
|
N,N'-((1R,4R)-CYCLOHEXANE-1,4-DIYL)BIS(2-(4-CHLOROPHENOXY)ACETAMIDE);N,N'-1,4-环己烷二基二[2-(4-氯苯氧基)乙酰胺];CS-1442
|
C22H24Cl2N2O4 |
451.34296 | |
|
L-Isoleucine
|
73-32-5 |
L-异亮氨酸
|
Α-氨基-Β-甲基戊酸;异白氨酸;L-异亮氨酸 AJI88,USP23,FCCIII,CP2000;異亮氨酸;Α-胺-Β-甲基戊酸;異白胺酸;L-2-氨基-3-甲基戊酸;L-异亮氨酸
|
C6H13NO2 |
131.17 | 200-798-2 |
|
ISAVUCONAZOLE
|
241479-67-4 |
艾沙康唑
|
ISAVUCONAZOLE艾沙康唑;艾莎康唑;艾沙康唑-活性化合物;艾沙康唑ISAVUCONAZOLE 241479-67-4;艾沙康唑中间体M10;爱莎康唑;艾沙康挫
|
C22H17F2N5OS |
437.46 | 1592732-453-0 |
|
7-Ethyl-10-hydroxycamptothecin
|
86639-52-3 |
7-乙基-1-羟基喜树碱
|
7-乙基-10-羟基喜树碱(SN-38);喜树碱7-乙基-10-羟基杂质;7-乙基-10-羟基喜树碱;伊立替康中间体;7-乙基-10-羟基喜树;7-乙基-10-羟基喜树碱(伊立替康中间体);伊立替康杂质B;伊立替康相关物质B
|
C22H20N2O5 |
392.4 | 643-093-9 |
|
Irinotecan Hydrochloride Trihydrate
|
136572-09-3 |
盐酸伊立替康三水合物
|
CPT 11;CAMPTOSAR;CAMPTO;IRINOTECAN;盐酸伊立替康三水合物;盐酸依立替康三水合物;三水盐酸伊立替康;(+)-(4S)-4,11-二乙基-4-羟基-9-[(4-派啶基派啶)羰基]-1H-吡喃并[3,4:6,7]吲哚嗪[1,2B]喹啉-3,14-(4H,12H)-二酮盐酸盐;盐酸伊立替康三水合物(盐酸依立替康三水合物);盐酸伊立替康三水;盐酸伊立替康(标准品)
|
C33H45ClN4O9 |
677.18 | 603-967-2 |
|
IRAK-1-4 Inhibitor I
|
509093-47-4 |
IRAK-1-4 抑制剂 I
|
CS-1991;IRAK-1-4 抑制剂 I;IRAK-1-4 INHIBITOR I ;INTERLEUKIN-1 RECEPTOR-ASSOCIATED-KINASE-1;4 INHIBITOR;IRAK-1;4 抑制剂
|
C20H21N5O4 |
395.417 | |
|
Inositol
|
87-89-8 |
肌醇
|
肌醇;试剂级肌醇 科研专用;肌醇;肌醇原料;肌醇制药用;肌醇;CYCLOHEXANE-1,2,3,4,5,6-HEXOLCYCLOHEXANE-1,6-HEXOL;肌醇
|
C6H12O6 |
180.16 | 201-781-2 |
|
Inosine
|
58-63-9 |
肌苷
|
INOSINE,FREE BASE 肌苷;肌苷(INOSINE);肌苷标准品;肌苷,97%;(-)-肌苷;肌苷(RI);10-D-核糖次黄嘌呤;次黄苷
|
C10H12N4O5 |
268.23 | 200-390-4 |
|
INK 128
|
1224844-38-5 |
3-(2-氨基-5-苯并恶唑基)-1-(1-甲基乙基)-1H-吡唑并[3,4-D]嘧啶-4-胺
|
沙帕色替;SAPANISERTIB (INK 128,MLN0128,TAK-228);INK 128;INK128;INK 128 (MLN0128);INK-128;MLN0128;5-(4-氨基-1-异丙基-1H-吡唑并[3,4-D]嘧啶-3-基)苯并[D]恶唑-2-胺;3-(2-氨基-5-苯并恶唑基)-1-(1-甲基乙基)-1H-吡唑并[3,4-D]嘧啶-4-胺;3-(2-氨基-5-苯并恶唑基)-1-(1-甲基乙基)-1H-吡唑并[3,4-D]嘧啶-4-胺(INK-128);SAPANISERTIB,一种有效的,选择性的 MTOR 抑制剂
|
C15H15N7O |
309.3259 | |
|
INH1
|
313553-47-8 |
N-[4-(2,4-二甲基苯基)-2-噻唑基]苯甲酰胺
|
CS-1011;N-[4-(2,4-二甲基苯基)-2-噻唑基]苯甲酰胺
|
C18H16N2OS.HCl |
345 | |
|
Indole-3-Carbinol
|
700-06-1 |
吲哚-3-甲醇
|
3-羥吲哚;吲哚-3-甲醇,97%;3-吲哚甲醇酸;3-吲哚;吲哚三甲醇;吲哚-3-甲醇(3-吲哚甲醇);3-羟甲氧基吲哚;3-吲哚甲醇
|
C9H9NO |
147.17 | 211-836-2 |
|
INCB28060
|
1029712-80-8 |
卡马替尼
|
苯扎米特;苯扎米特 INCB28060;INCB28060(苯扎米特);CAPMATINIB (INCB28060);2-氟-N-甲基-4-[7-[(喹啉-6-基)甲基]咪唑并[1,2-B]-[1,2,4]三嗪-2-基]苯甲酰胺;苯扎米特
|
C23H17FN6O |
412.4190832 | 813-241-9 |
|
INCB024360
|
914471-09-3 |
4-氨基-N-(3-氯-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒
|
4-氨基-N-(3-氯-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒;CS-1034;INCB-024360;INCB 024360;INCB-24360;INDOLEAMINE-2;3-DIOXYGENASE INHIBITOR INCB024360;(E)-4-氨基-N-(3-氯-4-氟苯基)-N'-羟基-1,5-二唑-3-甲脒;INCB 024360 类似物;INCB024360 ANALOGUE;IDO5L;INCB024360 500MG;(E)-4-氨基-N'-(3-氯-4-氟苯基)-N-羟基-1,5-恶二唑-3-甲脒
|
C9H7ClFN5O2 |
271.6355832 |
药智官方微信
药智官方微博
